In patients with severe refractory immune thrombocytopenia (ITP), especially those unable to receive blood transfusions due to religious beliefs, alternative non-cytotoxic therapies are important to avoid worsening cytopenias. Immunomodulatory agents such as mycophenolate mofetil and daratumumab should be used alongside traditional therapies including steroids, IVIG and rituximab.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11780247 | PMC |
| http://dx.doi.org/10.1002/ccr3.70102 | DOI Listing |
Publication Analysis
Top Keywords
severe refractory
8
bloodless management
4
management severe
4
refractory itp
4
itp acute
4
acute hemorrhage
4
hemorrhage jehovah's
4
jehovah's witness
4
witness patient
4
patient patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!